You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 14, 2025

Details for Patent: 10,098,877


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,098,877
Title:Methods and compositions for treating diabetes, metabolic syndrome and other conditions
Abstract: Pharmaceuticals compositions comprising the 2S, 4R, ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2R, 4S ketoconazole enantiomer are useful to reduce cortisol synthese and for the treatment of type 2 diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other diseases and conditions, including but not limited to Cushing's Syndrome, depression, and glaucoma.
Inventor(s): Marin; Per (Vastra Frolunda, SE)
Assignee: Strongbridge Ireland Limited (Trevose, PA)
Application Number:15/886,437
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction to Patents and Their Significance

Patents are a cornerstone of innovation, providing inventors with exclusive rights to their creations and incentivizing the development of new technologies. In the United States, the U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents, which can be crucial for businesses and individuals alike.

What is a Patent?

A patent is a grant of a property right to the inventor of a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. This grant gives the patent holder the exclusive right to make, use, or sell the invention for a specified period, typically 20 years from the date of the first filing of the patent application[5].

The Patenting Process

The process of obtaining a patent involves several steps, including the submission of a patent application, examination by the USPTO, and potential revisions based on feedback from the examiner. The application must include detailed descriptions and claims that define the scope of the invention[2].

Patent Scope and Claims

The scope of a patent is defined by its claims, which are the legal boundaries of what the patent protects. Two key metrics for measuring patent scope are independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent, with narrower claims often associated with a higher probability of grant and a shorter examination process[3].

Example: U.S. Patent 10,098,877

To illustrate the analysis of patent scope and claims, let's consider a hypothetical example using U.S. Patent 10,098,877, although the specific details of this patent are not provided here.

Patent Claims

  • Independent Claims: These are the core claims that define the invention. They must be clear, concise, and distinguishable from prior art.
  • Dependent Claims: These claims build upon the independent claims, often adding specific details or limitations.

Patent Scope

  • The scope of a patent is determined by the language used in the claims. Broader claims may cover a wider range of applications, but they also risk being deemed overly broad or invalid.
  • Claim Language: The clarity and specificity of claim language are crucial. For instance, a patent with shorter, more precise independent claims may have a clearer scope and be more likely to be granted quickly[3].

Technological Classification

Patents are classified technologically under the World Intellectual Property Organization (WIPO) classification, which includes 35 International Patent Classification (IPC) technical fields. This classification helps in understanding the technological area in which the patent is granted and its relevance to other inventions in the same field[1].

Geographic Allocation

Patents are allocated geographically according to patent inventorship information. This helps in tracking the origin of inventions and understanding the global distribution of innovative activities. For example, in 2018, U.S. inventors received patents on approximately 46,000 international patent families, while China had the largest number of international patent families granted[1].

Patent Term and Restoration

The patent term in the United States is generally 20 years from the date of the first filing of the patent application. However, for certain products, such as human drugs and medical devices, the effective patent term can be shorter due to the time spent in regulatory review. The Patent Term Restoration Program allows for the extension of the patent term to compensate for this lost time, ensuring that patent holders can recoup some of the time spent awaiting FDA approval[5].

Role of the FDA in Patent Term Restoration

The FDA plays a critical role in determining a product's eligibility for patent term restoration. It provides information to the USPTO regarding the regulatory review period and assists in determining the period of patent extension. The FDA also handles due diligence petitions and hearings related to the patent term restoration process[5].

Impact on Innovation

Patents, including their scope and claims, significantly impact innovation. Clear and well-defined claims can encourage further innovation by providing a clear understanding of what is protected and what is open for further development. Conversely, overly broad or unclear claims can lead to increased litigation and licensing costs, potentially stifling innovation[3].

Global Patent Trends

The global patent landscape is dynamic, with countries like China, the European Union, Japan, and South Korea showing significant growth in patent filings. In 2018, China had the largest number of international patent families granted, with an almost eightfold increase from 2008. This trend highlights the global nature of innovation and the importance of patents in driving technological advancement[1].

Key Takeaways

  • Patent Scope: Defined by the claims, which must be clear and specific.
  • Patent Claims: Independent and dependent claims define the invention and its boundaries.
  • Technological Classification: Helps in understanding the technological area and relevance to other inventions.
  • Geographic Allocation: Tracks the origin of inventions and global distribution of innovative activities.
  • Patent Term and Restoration: Ensures that patent holders can recoup time lost in regulatory review.
  • Global Trends: Reflect the dynamic nature of innovation and the importance of patents globally.

FAQs

1. What is the primary purpose of a patent?

  • The primary purpose of a patent is to grant the inventor exclusive rights to their invention, encouraging innovation by protecting their creation from direct competition.

2. How are patents classified technologically?

  • Patents are classified technologically under the World Intellectual Property Organization (WIPO) classification, which includes 35 International Patent Classification (IPC) technical fields.

3. What is the Patent Term Restoration Program?

  • The Patent Term Restoration Program extends the patent term to compensate patent holders for the time lost while awaiting FDA approval for certain products.

4. What role does the FDA play in patent term restoration?

  • The FDA assists the USPTO in determining a product’s eligibility for patent term restoration and provides information regarding the regulatory review period.

5. Why are clear and specific patent claims important?

  • Clear and specific patent claims are important because they define the scope of the invention clearly, reducing the risk of litigation and encouraging further innovation.

Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov.
  3. Patent Claims and Patent Scope - SSRN.
  4. Methods of treating disease with levoketoconazole - PubChem.
  5. Frequently Asked Questions on the Patent Term Restoration Program - FDA.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,098,877

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Strongbridge RECORLEV levoketoconazole TABLET;ORAL 214133-001 Dec 30, 2021 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME FOR WHOM SURGERY IS NOT AN OPTION OR HAS NOT BEEN CURATIVE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,098,877

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E528005 ⤷  Try for Free
Australia 2006204334 ⤷  Try for Free
Canada 2594433 ⤷  Try for Free
China 101141964 ⤷  Try for Free
Cyprus 1112519 ⤷  Try for Free
Denmark 1853266 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.